Intrexon plans rapid expansion after $25M venture round

Blacksburg, VA-based Intrexon has garnered $25 million in its third round of venture capital. Much of that money has been earmarked to fund the company's pre-clinical work in gene-based therapies. CEO Robert Beech told reporters that the money would allow the company to triple in size by the end of the year, swelling its work force to about 130. Intrexon moved from Cincinnati in 2004 when it had only four employees. New River Management provided the new funding.

- here's the report from The Roanoke Times  

ALSO: Hercules Technology Growth Capital is providing $10 million in venture debt financing to Neosil. Release 

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.